Youth Pharma And Chemicals Profile
Key Indicators
- Authorised Capital ₹ 5.00 Cr
- Paid Up Capital ₹ 4.95 Cr
- Company Age 4 Year, 7 Months
- Last Filing with ROC 31 Mar 2024
- Open Charges ₹ 27.50 Cr
- Revenue Growth %
- Net Worth 15.10%
- Total Assets 37.56%
About Youth Pharma And Chemicals
Youth Pharma And Chemicals Private Limited (YPACPL) is a Private Limited Indian Non-Government Company incorporated in India on 03 July 2020 (Four years and seven months 24 days old ). Its registered office is in Bharuch, Gujarat, India.
The Company is engaged in the Pharma Industry.
The Company's status is Active, and it has filed its Annual Returns and Financial Statements up until 31 March 2024. It's a company limited by shares with an authorized capital of Rs 5.00 Cr and a paid-up capital of Rs 4.95 Cr.
The company currently has active open charges totaling ₹27.50 Cr.
Bulish Banka, Ankit Agarwal, and Sabita Tibra serve as directors at the Company.
Company Details
- Location
Bharuch, Gujarat, India
- Telephone
+91-XXXXXXXXXX
- Email Address
- Website
-
- Social Media -
Corporate Identity Details
- CIN/LLPIN
U24296GJ2020PTC114323
- Company No.
114323
- Company Classification
Private Limited Indian Non-Government Company
- Incorporation Date
03 Jul 2020
- Date of AGM
30 Sep 2024
- Date of Balance Sheet
31 Mar 2024
- Listing Status
Unlisted
- ROC Code
Roc Ahmedabad
Industry
Who are the key members and board of directors at Youth Pharma And Chemicals?
Board Members (3)
| Name | Designation | Appointment Date | Status |
|---|---|---|---|
Ankit Agarwal  | Director | 03-Jul-2020 | Current |
| Bulish Banka | Director | 03-Jul-2020 | Current |
| Sabita Tibra | Director | 19-Mar-2021 | Current |
Financial Performance of Youth Pharma And Chemicals.
Youth Pharma And Chemicals Private Limited, for the financial year ended 2022, experienced no change in revenue, with a 0% increase. The company also saw a no change in profitability, with a 0% increase in profit. The company's net worth Soared by an impressive increase of 15.1%.
- Key Matrics
- Balance Sheet
- Profit and Loss
- Cash Flow
- Ratios
| Metrics |
| (FY 2022) | (FY 2021) | (FY 2020) | (FY 2019) | ||
|---|---|---|---|---|---|---|---|
| Total Revenue | |||||||
| Revenue from Operations | |||||||
| Total Assets |
| ||||||
| Profit or Loss | |||||||
| Net Worth |
| ||||||
| EBITDA |
What is the Ownership and Shareholding Structure of Youth Pharma And Chemicals?
In 2021, Youth Pharma And Chemicals had a promoter holding of 100.00%. Access key insights, ownership, including shareholding patterns, funding, foreign investors, KMP remuneration, group structure, and overseas investments.
Charges (Loans)
₹27.50 Cr
₹0
Charges Breakdown by Lending Institutions
- Others : 27.50 Cr
Latest Charge Details
| Date | Lender | Amount | Status |
|---|---|---|---|
| 28 Jul 2022 | Others | ₹13.75 Cr | Open |
| 21 Jul 2022 | Others | ₹13.75 Cr | Open |
How Many Employees Work at Youth Pharma And Chemicals?
Youth Pharma And Chemicals has a workforce of 0 employees as of Apr 06, 2024. Unlock access to detailed historical data on individuals associated with the company, including employment records, contributions to the Employees' Provident Fund Organization (EPFO), and other related insights.
Deals i
Gain comprehensive insights into the Deals and Valuation data of Youth Pharma And Chemicals, offering detailed information on various transactions, including security allotment data. Explore the intricate details of financial agreements, mergers, acquisitions, divestitures, and strategic partnerships that have shaped Youth Pharma And Chemicals's trajectory.
Rating
Access the credit rating data, providing valuable insights into the company's creditworthiness and financial stability. Explore assessments from leading credit rating agencies, evaluating factors such as debt obligations, liquidity, profitability, and overall financial health.
Alerts
Stay informed about regulatory alerts and litigation involving and associated companies. Receive timely updates on legal proceedings, regulatory changes, and compliance issues that may impact the company's operations, reputation, and financial performance. Monitor litigation involving subsidiaries, joint ventures, and other affiliated entities to assess potential risks and liabilities.